Find Academic Supervisors

Danny ManorView profile

Professor

• Signal Transduction
• Oncology
• Nutrition
• +6 more

Roles & Affiliations: Danny Manor is a Professor in the Departments of Nutrition and Pharmacology at Case Western Reserve University School of Medicine, and serves as Vice Chair of the Department of Nutrition. He holds additional roles as a Member of the Molecular Oncology Program at the Case Comprehensive Cancer Center. Education: Ph.D. in Anatomy, Structural Biology & Biophysics from Albert Einstein College of Medicine (1989); B.Sc. in Biochemistry from Tel Aviv University (1982). Research Focus: Dr. Manor’s research centers on growth factor signaling pathways, particularly those involving Rho GTPases and Dbl family guanine nucleotide exchange factors (GEFs). His work explores the molecular mechanisms underlying aberrant cell functions in cancer and other diseases. A major emphasis is on vitamin E’s role in health and disease, including its effects on reactive oxygen species, neurodegeneration, and metabolic disorders. His interdisciplinary approach integrates molecular/cell biology, biophysics, synthetic chemistry, and microscopy, with translational collaborations in clinical research. Grants & Funding: Recent grants include NIH/NCI R21 CA254968 (2021–2023) for targeting Tiam1 in cancer and NIH/NIDDK R01 DK125115 (2021–2026) investigating vitamin E and the tocopherol transfer protein. Labs & Teams: Leads the Manor Lab, which focuses on signal transduction, vitamin E mechanisms, and cancer biology. Collaborates with epidemiologists, geneticists, and clinicians to bridge basic and translational research.

• Health Communication
• Cyberbullying Prevention
• Public Health Campaigns
• +3 more

Matthew W. Savage is an Associate Professor at the School of Communication, San Diego State University (SDSU), specializing in health and interpersonal communication. His research focuses on adolescent bullying/cyberbullying, oral health promotion, and reciprocal violence, emphasizing team science and community partnerships with educational, governmental, and non-profit organizations. He holds a Ph.D. from Arizona State University (2012) and has taught at institutions including the University of Kentucky, University of Hawaii, and Arizona State University, where he received prestigious university teaching awards. His courses include Quantitative Methods in Communication, Health Communication and Relationships, and seminars in Health Communication and Research Methods. Dr. Savage's research integrates behavioral health interventions, public health campaigns, and technology-based solutions to address risky behaviors among adolescents and young adults. Notable projects include cyberbullying prevention strategies, oral health initiatives in Appalachia, and pandemic-related health behavior studies during the COVID-19 crisis. His work has been supported by external and internal funding mechanisms, translating academic research into clinical practice. He actively explores how communication strategies impact policy compliance, vaccine sentiment, and media framing of health issues such as intimate partner violence.

• Urologic Oncology
• Biomarker Development
• Clinical Trial Design
• +3 more

Fed Ghali, MD, is an Assistant Professor of Urology at the Yale School of Medicine, specializing in urologic oncology with expertise in bladder, ureter, kidney, and testicular cancers. He holds affiliations with Yale Cancer Center, Prostate & Urologic Cancers Program, and Urologic Oncology at Yale School of Medicine. Ghali completed his medical degree at Geisel School of Medicine, residency in Urology at UC San Diego, and a Society of Urologic Oncology fellowship at the University of Washington. His research focuses on clinical trial design, biomarker development for bladder cancer, and improving patient outcomes through personalized therapy. Notable interests include non-muscle invasive bladder cancer recurrence detection via urinary DNA analysis and optimizing treatment protocols for variant histology cancers. He collaborates with institutions nationally to advance therapeutic strategies and biomarker discovery. Ghali emphasizes patient-centered care, balancing high-volume clinical practice with compassionate individualized treatment. He actively participates in Yale's translational research initiatives and clinical trials to bring cutting-edge therapies to patients. His work highlights the integration of surgical innovation, molecular diagnostics, and clinical research in oncology.

• Drug Delivery Systems
• Biomaterials Engineering
• Tissue Regeneration
• +3 more

Katie Ryan is a Senior Lecturer in Pharmaceutics at the School of Pharmacy, University College Cork (UCC). She holds a BSc in Pharmacy from Trinity College Dublin (TCD) and a PhD in Pharmaceutics (TCD), with postgraduate qualifications in Quality Improvement (TCD) and Teaching & Learning (UCC). She is a member of the UK & Ireland Controlled Release Society, serving as its President (2017-2020). Education & Professional Roles: BSc (Pharmacy), Trinity College Dublin (2001) MSc (Pharmaceutics), Trinity College Dublin (2007) Postgraduate Diploma in Statistics (2004) MA in Teaching & Learning in Higher Education (UCC, 2010) Research Focus: Her work centers on biomaterial-driven drug delivery systems for ocular, orthopedic, and bone regeneration applications. Key areas include: Sustained drug release via PLGA and hydroxyapatite scaffolds S1P receptor modulation in bone and retinal regeneration Combination therapies for implant-associated infections Bioengineered models for drug screening in metastatic cancers Grants & Funding: PI/co-PI of projects totaling >€1.2M from SFI, Enterprise Ireland, and industry collaborations. Active in the SFI-funded SSPC Centre. Awards & Recognition: Aspiring Leaders Leadership Programme (UCC, 2021) Erasmus Staff Mobility Grants (2021, 2016, 2014, 2012, 2011) Best Oral Prize at Irish Pharmacology Association (2021) Teaching & Outreach: Develops critical thinking curricula for pharmacy students. Leads STEM engagement initiatives in Cork schools, including Visual Thinking Strategies workshops. Chairs UCC's School of Pharmacy Staff-Student Committee. Labs & Collaborations: Collaborates with Harvard University (Prof. David Mooney) and Tyndall National Institute (Prof. Martyn Pemble). Active in the COST Action IMPROVE network and serves on editorial boards for Journal of Pharmaceutical Sciences .

• Mathematical Analysis
• Applied Mathematics
• Optimal Control Theory
• +3 more

Matteo Fornoni is a Research Fellow at the Department of Mathematical Analysis and Applications, University of Pavia. His research focuses on mathematical models for tumor growth dynamics, optimal control theory, and inverse problems in biomedical applications. He specializes in developing and analyzing partial differential equation-based models for cancer progression and medical imaging applications. Recent work emphasizes personalized tumor forecasting, early tumor state reconstruction, and mathematical analysis of non-local models. His 2023-2025 publications demonstrate expertise in Cahn-Hilliard systems, viscous tumor growth models, and Sobolev space convergence in nonsmooth domains. Key technical contributions include iterative algorithms for prostate cancer reconstruction, maximal regularity analysis for tumor models, and optimal control strategies for biomedical systems. Maintains active collaboration through his research group's activities. Currently affiliated with the University of Pavia's Mathematical Analysis and Applications research group, contributing to both theoretical advancements and applied biomedical modeling challenges.

Paul KwanView profile

Associate Professor

• Prostate Cancer Research
• Medical Education
• Pathology
• +6 more

Paul Kwan is an Associate Professor in the Department of Medical Education at Tufts University School of Medicine. He joined Tufts in 1975 after earning his Ph.D. from Clark University and has held various roles, including Research Assistant Professor in Pathology, Integrative Physiology and Pathobiology, and Immunology. He currently teaches full-time and serves as course director for Clinical Anatomy (Tufts University School of Dental Medicine) and Basic Human Pathology (Master’s in Biomedical Sciences Program). Doctor of Philosophy, Clark University (1975) Master of Arts, Clark University (1971) Bachelor of Science, University of Maryland (1966) Dr. Kwan’s research focuses on prostate cancer mechanisms, including androgen receptor dynamics, hormonal influences on neoplasia, and nutritional interventions like curcumin and vitamin E in cardiovascular and metabolic diseases. His work spans animal models, immunohistochemistry, and translational studies. Recent publications highlight curcumin’s role in ameliorating atherosclerosis and steatohepatosis, vitamin E’s impact on macrophage activity in hypercholesterolemic models, and mechanistic studies on prostate cancer progression. These reflect interdisciplinary interests in oncology, medical physiology, and nutritional science. Tufts Teaching with Technology Award (2021) Dean’s Award for Excellence in Basic Science Teaching (2016) He has taught courses such as Medical Histology, Basic Human Pathology, and Clinical Anatomy since the 1980s, with current appointments at Tufts University School of Medicine and School of Dental Medicine. His affiliations also include Tufts Medical Center (1975–2015) as Special and Scientific Staff.

Suneil JainView profile

Clinical Professor

• Prostate Cancer
• Radiotherapy
• Radiation Therapy and Drug Combination Studies
• +4 more

Suneil Jain is a Clinical Professor at Queen's University Belfast's School of Medicine, Dentistry and Biomedical Sciences, with a focus on prostate cancer and advanced radiotherapy. He leads the Belfast Manchester FASTMAN Movember/Prostate Cancer UK Centre of Excellence and has expertise in hypofractionated radiotherapy, biomarkers, and nanotechnology. His research includes clinical trials, translational studies, and collaborations across disciplines. He has secured 12 awards, including fellowships and research distinctions. Jain actively supervises PhD students and publishes extensively on prostate cancer treatment outcomes, radiation toxicity, and therapeutic innovations. His work aligns with UN Sustainable Development Goals related to health and well-being.

Aidan ColeView profile

Senior Lecturer

• Radiation Therapy
• Prostate Cancer
• Radiobiology
• +5 more

Dr Aidan Cole is a Clinical Senior Lecturer at Queen's University Belfast's School of Medicine, Dentistry, and Biomedical Sciences. He is a key member of the Patrick G Johnston Centre for Cancer Research and actively involved in clinical academic research focusing on prostate cancer treatment, radiobiology, and radiation oncology. His work combines medical physics, radiation biology, and clinical practice to improve patient outcomes. Education: PhD in Radiobiology from Queen's University Belfast (2014). Awards include the ESTRO Accuray Award (2013), St. Lukes Medal (2016), and the Belfast Trust Chairman's Award (2024). He has been shortlisted for the QUB Staff Excellence Awards (Innovation category) and received recognition for research culture contributions. Research Interests: Radiobiology of targeted radionuclides (e.g., Radium-223), stereotactic radiotherapy, immunotherapy, and radiation-induced cardiotoxicity. His group explores biomarkers for radiosensitivity, cardiac toxicity mitigation, and precision radiation oncology. Publications include studies on OSCE assessment authenticity, biomarker development for prostate cancer, and radiation toxicity in lung cancer patients. He has led clinical trials such as the SPORT and TRAP trials, advancing SBRT/SABR protocols for oligometastatic disease. Grants: Active projects include Movember Centre of Excellence (Movember COE) and Clinical Research Fellowship in Radiotherapy. He supervises postgraduate research in imaging biomarkers and radium-223 applications. Labs/Teams: Principal investigator at the Patrick G Johnston Centre for Cancer Research. Collaborates internationally on radiation oncology and translational cancer research.

• Medical Oncology
• Prostate Cancer
• Castration Resistant Prostate Cancer
• +7 more

Paul Hamberg is affiliated with Erasmus MC in the field of Medical Oncology, where he conducts active research in prostate cancer and related urological malignancies. His work is centered on clinical and translational oncology, with a strong focus on biomarker development and treatment response prediction. Institution: Erasmus MC Division: Medical Oncology His research interests include prostate cancer, castration-resistant prostate cancer, pharmacokinetics, precision medicine, and immune checkpoint inhibitors. He investigates novel biomarkers such as cell-free DNA aneuploidy scores and T-cell-to-stroma enrichment (TSE) to predict therapeutic outcomes. His work also explores advanced imaging techniques like PSMA PET/CT for cancer management. The recent articles highlight a strong trend toward personalized oncology, integrating molecular profiling, metabolic insights, and innovative trial designs. His publications span high-impact journals such as Nature Communications and Molecular Oncology , reflecting a multidisciplinary approach that bridges clinical practice and research. While no specific scientific awards are listed in the provided text, his extensive publication record and collaborative research indicate significant recognition in the oncology community. Paul Hamberg has contributed to the supervision of at least one research work, as indicated by the 'Supervised Work (1)' mention. His involvement in multiple clinical trials and collaborative studies demonstrates active engagement in research mentoring and team science. There is no mention of specific grants, but his participation in complex trials suggests involvement in funded research initiatives. He is part of a robust research network at Erasmus MC, collaborating with experts in urology, nuclear medicine, and molecular oncology. His work is embedded in multidisciplinary teams focused on improving outcomes in prostate and renal cancers.

• Urology
• Urooncology
• Endourology
• +3 more

Yılmaz Aslan is a Professor and Head of the Department of Urology at Üsküdar University Faculty of Medicine. He obtained his MD from Çukurova University Faculty of Medicine in 1999 and completed his urology residency at Ankara Numune Education and Research Hospital in 2005. He holds expertise in urology, urooncology, endourology, andrology, and BPH management. His career includes international collaborations, including a fellowship at Jikei University in Japan and a decade of surgical initiatives across Balkans, Africa, and Central Asia under the Turkish Ministry of Health. Education: Bachelor of Medicine: Çukurova University Faculty of Medicine (1999) Urology Specialty Training: Ankara Numune Education and Research Hospital (2005) Fellowship: Jikei University School of Medicine, Tokyo (2009) under Prof. Shin Egawa Research Interests: Focus on minimally invasive urological surgeries, adrenal gland disorders, retrograde intrarenal surgery (RIRS), and outcomes of testis-sparing surgeries. His work emphasizes surgical innovation, antibiotic prophylaxis in transurethral procedures, and interdisciplinary approaches to complex cases. Publications & Awards: Over 60 international indexed articles, 40 national publications, and 7 awards. His top studies address adrenal surgery techniques, Fournier gangrene prognosis, and comparative outcomes between robotic and laparoscopic procedures. Administration & Grants: Current Head of Urology since 2022. Active in professional associations and has supervised numerous multicenter studies. Research interests include adrenal incidentalomas, prostate cancer detection post-prostatectomy, and sexual function post-surgery rehabilitation. Labs/Teams: Coordinates international collaborations through the Eurasian Uro-Oncology Association, focusing on testicular mass management and surgical innovations.

Peter HeathcoteView profile

Professor

• Photosynthetic Reaction Centres
• Protein Cofactor Interactions
• Respiratory Chain Complexes
• +2 more

Peter Heathcote is Professor of Biochemistry and Co-Director of the Nanchang Joint Programme at Queen Mary University of London's School of Biological and Behavioural Sciences. His research focuses on biochemical mechanisms in photosynthesis and enzymatic systems, with expertise in spectroscopic analysis of protein-cofactor interactions. Research Interests: Heathcote investigates electron transfer pathways in photosynthetic reaction centres (Type I), respiratory complexes, and tetrapyrrole biosynthesis enzymes. His work employs advanced spectroscopic techniques to study redox cofactors and energy transfer in biological systems. Publication Trends: Recent publications bifurcate into two domains: (1) Continued biophysics research on photoexcitation and spectroscopy techniques, and (2) Clinical prostate cancer studies addressing diagnostic imaging (PSMA PET/MRI), surgical outcomes (robotic prostatectomy), and quality-of-life metrics. This reflects interdisciplinary engagement with medical applications. Awards & Advising: No awards or supervised students are documented in available materials.

Ryan HalterView profile

Professor

• Biomedical Instrumentation
• Medical Imaging
• Electrical Impedance Tomography (EIT)
• +7 more

**Ryan Halter** is a Professor of Engineering and Program Area Lead for Biomedical Engineering at Dartmouth College's Thayer School of Engineering. He also serves as an Adjunct Associate Professor of Surgery at the Geisel School of Medicine and Technical Associate Director of the Center for Precision Health and Artificial Intelligence (CPHAI). His research focuses on biomedical instrumentation, electrical impedance tomography (EIT), medical robotics, and surgical navigation systems for applications like cancer detection and trauma care. Education: BSc in Engineering Science and Mechanics, Pennsylvania State University (1999) MSc in Engineering Mechanics, Pennsylvania State University (2001) PhD in Biomedical Engineering, Dartmouth College (2006) Research Interests: Dr. Halter’s work emphasizes advancing EIT and bioimpedance techniques for diagnosing diseases such as prostate and breast cancer, monitoring traumatic brain injury, and enhancing surgical precision. He also explores space medicine applications, including technologies for long-term space missions. His lab develops wearable devices and imaging systems for clinical translation. Publications & Trends: Recent articles highlight EIT’s role in hemorrhage detection, robotic surgery navigation, and portable EEG systems. His work bridges electrical engineering, surgery, and clinical needs, with a focus on real-time monitoring and non-invasive diagnostics. Awards: Society of Critical Care Medicine’s Gold Snapshot Award (2021) DoD CDMRP New Investigator Award (2009-2012) Intuitive Surgical Research Fellowship (2009-2011) Advising & Grants: Dr. Halter mentors a dynamic team of PhD and undergraduate researchers and collaborates with startups like RyTek Medical and SynchroHealth. He leads NIH-funded projects and ARPA-H initiatives, including a $30M award for tumor removal technologies. Labs & Teams: The Halter Lab at Thayer School of Engineering collaborates with Dartmouth-Hitchcock Medical Center and industry partners to translate innovations into clinical practice. Key projects include the ENTerpoint Surgical Navigation System and EIT-based tools for space medicine.

Karen ChengView profile

Assistant Professor

• Radiation Oncology
• Intensity Modulated Radiation Therapy
• Stereotactic Body Radiation Therapy
• +16 more

Karen Cheng, M.D., is an Assistant Clinical Professor in the Department of Radiation Oncology at City of Hope, with clinical practice sites in Riverside and San Bernardino, California. She is actively involved in clinical care and academic medicine, specializing in advanced radiation therapies including intensity-modulated, stereotactic, and brachytherapy techniques for cancers of the breast, cervix, brain, head and neck, and prostate. Her educational background includes a Doctor of Medicine from Boston University School of Medicine (2015–2019) and a Bachelor of Science in Bioengineering from the University of California at Berkeley (2011–2015). She completed an internal medicine internship at North Shore University Hospital / LIJ Medical Center and a radiation oncology residency at USC/Los Angeles General Medical Center, where she served as chief resident. Dr. Cheng’s research spans radiation oncology innovation, radiomics, AI in imaging, and health equity. Her recent publications focus on technical advancements in brachytherapy, hippocampal-sparing techniques, radiomics datasets, and patient understanding of radiation therapy in diverse populations. This reflects a strong trend toward integrating technology with patient-centered care and addressing disparities in oncology. American College of Radiation Oncology Excellence in Mentorship Award Keck School of Medicine DEI Leaders Scholarship Boston University School of Medicine Anne and David Mischel Cancer Research Award MassChallenge Startup Accelerator Finalist Clinton Global Initiative University Innovation Fund Awardee Multiple grants and leadership awards in innovation, diversity, and research Dr. Cheng has been involved in numerous research projects and clinical initiatives, supported by grants from organizations such as the American Society of Clinical Oncology, Chinese American Medical Society, and Grand Challenges Canada. She has also participated in innovation competitions and hackathons, demonstrating a strong commitment to translational research and community impact. She is fluent in English, Mandarin, Taiwanese, and Spanish, enhancing her ability to serve diverse patient populations. She contributes to academic knowledge through a robust publication record and participation in developing clinical trials at City of Hope, a renowned institution for cancer care and research.

• Urology
• Reconstructive Surgery
• Bladder Cancer
• +5 more

Prof. Dr. med. Margit Fisch is a faculty member at the University Medical Center Hamburg-Eppendorf, affiliated with the Department of Urology. Her research focuses on reconstructive urology, bladder cancer outcomes, and transgender healthcare.

• Radiology
• Diagnostic Imaging
• Magnetic Resonance Imaging
• +7 more

Joan Carles Vilanova Busquets is an Associate Professor in the Department of Medical Sciences at the School of Medicine, University of Girona. He is also the Director of the Magnetic Resonance Institute at Clínica Girona, a Staff Consultant at the Institute of Diagnostic Imaging (IDI) of the Catalan Institute of Health, and the Chief of the Prostate Imaging Unit at the Dr. Josep Trueta University Hospital in Girona, Spain. His career is marked by significant leadership in national and international radiology societies. MD, Medicine, University of Barcelona (1988) PhD, Medicine, University of Barcelona (2008) Board Certified Radiologist, University Hospital Dr. J. Trueta, Girona Fellowship, American Forces Institute of Pathology (AFIP), Washington, DC, USA Dr. Vilanova's research is centered on advanced diagnostic imaging, particularly multiparametric MRI. His primary interests include the application of MRI in prostate cancer diagnosis and staging, musculoskeletal radiology, soft tissue tumor imaging, whole-body MRI, and functional imaging in oncology. His work bridges clinical practice with cutting-edge technological applications in medical imaging. The 15 most recent articles reflect a strong focus on the application of advanced MRI techniques in oncology. Key trends include the development and refinement of clinical guidelines for imaging soft tissue tumors and prostate cancer, the use of radiomics and artificial intelligence for diagnosis, and the technical optimization of MRI protocols for specific conditions like the diabetic foot and hepatobiliary disorders. His publications frequently appear in high-impact radiology journals and often involve collaborative, multi-institutional research. Dr. Vilanova has received numerous scientific honors, including: Recognition of the professional career of the Medical Association of Girona (2016) Award for research in Spanish Radiology - SERAM (Sevilla, 2008) Magna cum Laude at the European Congress of Radiology (ECR 2006) and the Radiological Society of North America (RSNA 2009) Multiple Cum Laude awards at international conferences (RSNA 2010, 2012, 2015; SERAM 2014) He has been a prolific advisor and researcher, with over 300 publications and participation in 40 research projects. He has held key leadership positions, such as Chairman of the Spanish Society of Musculoskeletal Radiology (SERME) and the Scientific Committee of the Spanish National Congress of Radiology (SERAM). He is also an active educator, focusing on integrating radiology into broader medical curricula. Dr. Vilanova leads a prominent research lab at the University of Girona and is a key member of the Aging Imageomics Study. His current work involves several teams focused on AI in medical imaging, prostate cancer imaging, and the application of functional MRI in various pathologies.